Related Experiment Video
Updated: Aug 11, 2026

09:49
Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
Pleural Fluid Cytology Yields and Time to Sample Processing
Kristin N Sheehan1, Arjun B Chatterjee2
1Department of Internal Medicine, Section on Pulmonary and Critical Care Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
The American Journal of Medicine
|August 4, 2026
Summary
The time between collecting pleural fluid samples and starting cytologic processing does not impact the diagnosis of malignant pleural effusions. This finding suggests clinicians can be confident in the diagnostic yield regardless of sample handling time.
Area of Science:
- Cytopathology
- Thoracic Medicine
- Oncology Diagnostics
Background:
- Pleural fluid cytology is crucial for diagnosing malignant pleural effusions.
- Optimizing the timing of cytologic evaluation is key to maximizing diagnostic yield.
- This study investigates the impact of pre-analytical time on pleural fluid cytology effectiveness.
Purpose of the Study:
- To assess the diagnostic yield of pleural fluid cytology in relation to the time elapsed between sample collection and laboratory processing.
- To determine if delays in processing affect the detection of malignant cells in pleural effusions.
Main Methods:
- Retrospective analysis of 327 thoracentesis-derived pleural fluid samples.
- Samples processed using Diff-Quik®, ThinPrep®, and cell block techniques.
- Logistic regression and log-risk models analyzed the association between time to processing and malignant diagnosis.
Main Results:
- No statistically significant difference in diagnostic yield was observed based on the time between sample collection and processing.
- The time of day or day of the week of sample collection did not correlate with diagnostic yield.
- Results remained consistent even after adjusting for sample volume.
Conclusions:
- The study did not find a significant association between delayed processing and reduced cytology yield for malignant cells.
- Clinicians can be reassured that the timing of diagnostic thoracentesis likely does not influence the probability of a malignant diagnosis.
- Further research into sample processing and storage conditions is recommended to enhance diagnostic yield.
